This inventor holds 2 USPTO granted patents. Top assignees: Samyang Genex Co., Samyang Genex Corporation. Active years: 1999-2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Taejon, KR (1999)
- Daejon, KR (2003)
Company Filing History:
Years Active: 1999-2003
Title: Hyun-Soo Lee: Innovator in Paclitaxel Production
Introduction
Hyun-Soo Lee is a notable inventor based in Daejon, South Korea. He has made significant contributions to the field of biotechnology, particularly in the production of paclitaxel, a vital compound used in cancer treatment. With a total of 2 patents, his work has implications for both industrial applications and medical advancements.
Latest Patents
One of Hyun-Soo Lee's latest patents focuses on the mass production of paclitaxel by changing the temperature of the medium during plant cell culture. This innovative method involves cultivating Taxus genus plant cells in a medium at approximately 20 to 25 degrees Celsius. Once the growth of the plant cells has progressed sufficiently, the cultivation temperature is adjusted to around 26 to 32 degrees Celsius to continue the culture. This approach not only enhances the production level of paclitaxel but also allows for convenient mass production, making it applicable in industrial settings.
Career Highlights
Throughout his career, Hyun-Soo Lee has worked with prominent companies, including Samyang Genex Corporation and Samyang Genex Co. His expertise in biotechnology has positioned him as a key figure in the development of innovative methods for producing essential compounds.
Collaborations
Hyun-Soo Lee has collaborated with notable colleagues such as Seung-Suh Hong and Ho-Joon Choi. These partnerships have contributed to the advancement of his research and the successful implementation of his patented methods.
Conclusion
Hyun-Soo Lee's contributions to the field of biotechnology, particularly in the production of paclitaxel, highlight his innovative spirit and dedication to improving medical treatments. His patents reflect a commitment to advancing industrial applications that can benefit society.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile